Mimedx Group Inc (NASDAQ: MDXG) kicked off on Tuesday, down -2.68% from the previous trading day, before settling in for the closing price of $7.83. Over the past 52 weeks, MDXG has traded in a range of $3.08-$9.27.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -1.19%. While this was happening, its average annual earnings per share was recorded -13.51%. With a float of $104.04 million, this company’s outstanding shares have now reached $146.23 million.
Let’s determine the extent of company efficiency that accounts for 895 employees.
Mimedx Group Inc (MDXG) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Mimedx Group Inc is 29.21%, while institutional ownership is 41.66%. The most recent insider transaction that took place on Mar 13 ’24, was worth 162,029. In this transaction General Counsel and CAO of this company sold 20,381 shares at a rate of $7.95, taking the stock ownership to the 479,959 shares. Before that another transaction happened on Feb 20 ’24, when Company’s Chief Operating Officer sold 15,271 for $8.01, making the entire transaction worth $122,351. This insider now owns 401,050 shares in total.
Mimedx Group Inc (MDXG) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/30/2023, the organization reported $0.32 earnings per share (EPS), higher than consensus estimate (set at $0.07) by $0.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -13.51% per share during the next fiscal year.
Mimedx Group Inc (NASDAQ: MDXG) Trading Performance Indicators
Take a look at Mimedx Group Inc’s (MDXG) current performance indicators. Last quarter, stock had a quick ratio of 3.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.48. Likewise, its price to free cash flow for the trailing twelve months is 45.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.34, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.43 in one year’s time.
Technical Analysis of Mimedx Group Inc (MDXG)
Looking closely at Mimedx Group Inc (NASDAQ: MDXG), its last 5-days average volume was 0.7 million, which is a drop from its year-to-date volume of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 21.24%. Additionally, its Average True Range was 0.28.
During the past 100 days, Mimedx Group Inc’s (MDXG) raw stochastic average was set at 55.41%, which indicates a significant increase from 1.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 23.97% in the past 14 days, which was lower than the 45.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.07, while its 200-day Moving Average is $7.49. However, in the short run, Mimedx Group Inc’s stock first resistance to watch stands at $7.82. Second resistance stands at $8.03. The third major resistance level sits at $8.13. If the price goes on to break the first support level at $7.51, it is likely to go to the next support level at $7.41. Now, if the price goes above the second support level, the third support stands at $7.20.
Mimedx Group Inc (NASDAQ: MDXG) Key Stats
The company with the Market Capitalisation of 1.12 billion has total of 146,958K Shares Outstanding. Its annual sales at the moment are 321,480 K in contrast with the sum of 58,230 K annual income. Company’s last quarter sales were recorded 86,830 K and last quarter income was 53,480 K.
